Assessment of the relationship between vascular endothelial growth factor and cardiovascular involvement in Egyptian patients with Behçet’s disease

Suzuki, 2004, Behcet’s disease, Clin Exp Med, 4, 10, 10.1007/s10238-004-0033-4 Mendes, 2009, Behçet’s disease—a contemporary review, J Autoimmun, 32, 178, 10.1016/j.jaut.2009.02.011 Gül, 2005, Behçet’s disease as an autoinflammatory disorder, Curr Drug Targets Inflamm Allergy, 4, 81, 10.2174/1568010053622894 Esmat, 2006, Lipoprotein (a) and nitrites in Behcet’s disease: relationship with disease activity and vascular complications, Eur J Dermatol, 16, 67 Clayton, 2008, Vascular endothelial growth factor-a specifies formation of native collaterals and regulates collateral growth in ischemia, Circ Res, 103, 1027, 10.1161/CIRCRESAHA.108.181115 Sezen, 2010, Cardiovascular involvement in Behçet’s disease, Clin Rheumatol, 29, 7, 10.1007/s10067-009-1302-0 Cocco, 2010, Behçet’s disease: an insight from a cardiologist’s point of view, Open Cardiovasc Med J, 4, 63 Marzban, 2008, Cardiac and great vessel involvement in ‘Behcet’s disease, J Card Surg, 23, 765, 10.1111/j.1540-8191.2008.00607.x Gasparyan, 2009, Recent advances in cardiovascular medicine: the tenth Iranian congress on cardiovascular update, Arch Iran Med, 12, 213 International Study Group for Behcet’s Disease, 1990, Criteria for diagnosis of Behcet’s disease, Lancet, 335, 1078 Bhakta, 1999, Behçet’s disease: evaluation of a new instrument to measure clinical activity, Rheumatology (Oxford), 38, 728, 10.1093/rheumatology/38.8.728 Leibowitz, 2007, Echocardiographic manifestations of Adamantiades-Behçet’s disease, Eur J Echocardiogr, 8, 457, 10.1016/j.euje.2006.07.013 Düzgün, 2006, Characteristics of vascular involvement in Behçet’s disease, Scand J Rheumatol, 35, 65, 10.1080/03009740500255761 Gül, 2008, Cardiovascular findings in Behçet’s disease, Acta Derm Venereol, 88, 285, 10.2340/00015555-0407 Tohmé, 2003, Vascular manifestations of Behçet’s disease. Eighteen cases among 140 patients, Joint Bone Spine, 70, 384, 10.1016/S1297-319X(03)00076-9 Ko, 2000, The vascular manifestations of Behçet’s disease: angiographic and CT findings, Br J Radiol, 73, 1270, 10.1259/bjr.73.876.11205670 Wechsler, 1999, Cardiovascular manifestations of Behcet’s disease, Ann Med Int, 150, 542 Gürgün, 2002, Cardiovascular involvement in Behcet’s disease, Jpn Heart J, 43, 389, 10.1536/jhj.43.389 Düzgün, 2013, Behçet’s disease and intracardiac thrombosis: a report of three cases, Case Rep Rheumatol, 2013, 637015 Hiwarkar, 2010, Deep vein and intracardiac thrombosis during the post-partum period in behçet’s disease, Int J Hematol., 91, 679, 10.1007/s12185-010-0538-4 Kaya, 2004, Behçet’s disease with right ventricle thrombus and bilateral pulmonary artery aneurysms: a case report, Angiology, 55, 573, 10.1177/000331970405500516 Hammami, 2005, Intracardiac thrombus in behçet’s disease: two case reports, Thromb J, 25, 1 Elqatni, 2011, Right atrium thrombus and pulmonary artery aneurysm in a man with behçet’s disease, Int Med, 50, 263, 10.2169/internalmedicine.50.4590 Hammami, 2012, Intracardiac thrombus in young man: don’t forget Behçet’s disease, Int Med, 51, 1865, 10.2169/internalmedicine.51.7640 Atzeni, 2005, Behçet’s disease and cardiovascular involvement, Lupus, 14, 723, 10.1191/0961203305lu2208oa Bardakci, 2007, Aortic arch aneurysm, pseudocoarctation, and coronary artery disease: in a patient with Behçet’s syndrome, Tex Heart Inst J, 34, 363 Ikonomidis, 2006, Arterial wave reflections are associated with left ventricular diastolic dysfunction in Adamantiades-Behçet’s disease, J Card Fail, 12, 458, 10.1016/j.cardfail.2006.04.001 Ozturk, 2008, Vascular endothelial growth factor and carotid intima-media thickness in patients with Behcet’s disease, Clin Rheumatol, 27, 961, 10.1007/s10067-007-0825-5 Bozoglu, 2005, Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet’s patients with venous thrombosis, Clin Exp Rheumatol, 23, S42 Kamoun, 2008, Vascular endothelial growth factor gene polymorphisms and serum levels in Behcet’s disease, Tissue Antigens, 72, 581, 10.1111/j.1399-0039.2008.01145.x Hamzaoui, 2009, VEGF and mRNA VEGF expression in CSF from Behçet’s disease with neurological involvement, J Neuroimmunol, 213, 148, 10.1016/j.jneuroim.2009.05.005 Cekmen, 2003, Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet’s syndrome, Int J Dermatol, 42, 870, 10.1046/j.1365-4362.2003.01688.x Erdem, 2005, Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet’s disease, Rheumatol Int, 25, 599, 10.1007/s00296-004-0484-7 Hassan, 2012, Subclinical atherosclerosis in Behçet’s disease, Turk J Rheumatol, 27, 109, 10.5606/tjr.2012.016 Messedi, 2011, Atherogenic lipid profile in Behçet’s disease: evidence of alteration of HDL subclasses, Arch Med Res, 42, 211, 10.1016/j.arcmed.2011.05.001 Oztürk, 2006, Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behçet’s disease, Rheumatol Int, 26, 867, 10.1007/s00296-005-0098-8 Seyahi, 2008, Atherosclerosis in Behçet’s syndrome, Semin Arthritis Rheum, 38, 1, 10.1016/j.semarthrit.2007.09.009 Seyahi, 2004, Coronary atherosclerosis in Behçet’s syndrome: a pilot study using electron-beam computed tomography, Rheumatology (Oxford), 43, 1448, 10.1093/rheumatology/keh359 Kayatas, 2013, Presence of low lipid levels in patients with Behcet’ s disease as a protector against atherosclerosis, Eur Rev Med Pharmacol Sci, 17, 2330 Lien, 2008, Therapeutic anti-VEGF antibodies, Handb Exp Pharmacol, 181, 131, 10.1007/978-3-540-73259-4_6